MICROBAC
Live / Registered — Registered — Section 8 accepted (as of 03 Jul 2023)
What this means for you
Registered since 28 Jun 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86698323
- Registration number
- 4986679
- Mark type
- Stylized text
- Filed
- 20 Jul 2015
- Published for opposition
- 12 Apr 2016
- Registered
- 28 Jun 2016
- Attorney of record
- Michelle E. Tochtrop
Goods and services
- Class 005 — Pharmaceuticals: Micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; Supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; Supplements, namely, dietary supplements for medical use and baby food, all the above containing liquid, solid, dried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposes, all the foregoing being for medical and veterinary use only
Owner
- PROBIOTICAL S.P.A., Novara (NO), IT
- PROBIOTICAL S.P.A., 28100 NOVARA, IT
- PROBIOTICAL S.P.A., 28100 NOVARA, IT
Prosecution history
- 08 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Dec 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Dec 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 10 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Dec 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 03 Jul 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED